Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  NASDAQ OMX COPENHAGEN  >  Novo Nordisk A/S    NOVO B   DK0060534915

NOVO NORDISK A/S

(NOVO B)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

NOVO NORDISK : Buy rating from Goldman Sachs

10/16/2020 | 01:51pm EST

Keyur Parekh from Goldman Sachs retains his positive opinion on the stock with a Buy rating. The target price is unchanged and still at DKK 484.


© MarketScreener with dpa-AFX Analyser 2020
Stocks mentioned in the article
ChangeLast1st jan.
NOVO NORDISK A/S 0.55% 415.1 Delayed Quote.7.36%
THE GOLDMAN SACHS GROUP, INC. 1.75% 239.58 Delayed Quote.2.41%
All news about NOVO NORDISK A/S
12/04NOVO NORDISK A/S : Files FDA New Drug Application for Obesity Drug
DJ
12/04NOVO NORDISK A/S : files for US FDA regulatory approval of once-weekly semagluti..
AQ
12/01NOVO NORDISK A/S : - Company announcements, trading in own shares
AQ
12/01NOVO NORDISK A/S : ESG presentation ()
PU
12/01NOVO NORDISK : Gets a Buy rating from JP Morgan
MD
11/30Weight-Loss Firm Noom Names First CFO
DJ
11/23NOVO NORDISK A/S : – Share repurchase programme
AQ
11/20India's Gland Pharma jumps 23% in market debut
RE
11/18NOVO NORDISK A/S : - Once-weekly semaglutide 2.0 mg demonstrates superior reduct..
AQ
11/18NOVO NORDISK A/S : Experts Urge Govt to Subsidise Cost of Diabetes Management, T..
AQ
More news
Financials
Sales 2020 127 B 20 754 M 20 754 M
Net income 2020 42 166 M 6 869 M 6 869 M
Net cash 2020 8 472 M 1 380 M 1 380 M
P/E ratio 2020 22,9x
Yield 2020 2,17%
Capitalization 961 B 157 B 157 B
EV / Sales 2020 7,47x
EV / Sales 2021 7,02x
Nbr of Employees 44 326
Free-Float 75,1%
Chart NOVO NORDISK A/S
Duration : Period :
Novo Nordisk A/S Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends NOVO NORDISK A/S
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 27
Average target price 439,69 DKK
Last Close Price 415,10 DKK
Spread / Highest target 31,3%
Spread / Average Target 5,92%
Spread / Lowest Target -30,1%
EPS Revisions
Managers
NameTitle
Lars Fruergaard Jørgensen President & Chief Executive Officer
Helge Lund Chairman
Maziar Mike Doustdar Executive Vice President-International Operations
Karsten Munk Knudsen Chief Financial Officer & Executive Vice President
Mads Krogsgaard Thomsen Chief Science Officer & Executive Vice President
Sector and Competitors
1st jan.Capitalization (M$)
NOVO NORDISK A/S7.36%156 651
JOHNSON & JOHNSON3.02%395 592
ROCHE HOLDING AG-3.74%290 107
PFIZER, INC.8.67%224 226
MERCK & CO., INC.-9.91%207 311
NOVARTIS AG-11.64%207 247